| Completed | A Long-Term Safety Study Evaluating the Safety and Systemic Exposure of AR-15512 Dry Eye Disease | Phase 3 | 2022-11-01 |
| Completed | Study Evaluating the Safety and Efficacy of AR-15512 (COMET-3) Dry Eye Disease | Phase 3 | 2022-07-18 |
| Completed | Study Evaluating the Safety and Efficacy of AR-15512 Dry Eye Disease | Phase 3 | 2022-05-09 |
| Completed | Rocklatan® Evaluation Glaucoma | Phase 4 | 2022-03-28 |
| Completed | Study Evaluating Techniques for Measuring Tear Production Dry Eye Disease | Phase 1 | 2021-12-09 |
| Completed | Efficacy and Safety Study of Netarsudil 0.02% Ophthalmic Solution Compared to Ripasudil Hydrochloride Hydrate Primary Open Angle Glaucoma, Ocular Hypertension | Phase 3 | 2020-11-30 |
| Completed | A Phase 2b Study Evaluating the Safety and Efficacy of AR-15512 Ophthalmic Solution for the Treatment of Dry E Dry Eye Disease | Phase 2 | 2020-10-26 |
| Completed | A Phase 2 Study Evaluating the Safety and Efficacy of Netarsudil Ophthalmic Solution in Patients With Corneal Corneal Edema | Phase 2 | 2020-09-17 |
| Completed | A Study Assessing AR-13503 Implant in Subjects With nAMD or DME Neovascular Age-related Macular Degeneration, Diabetic Macular Edema | Phase 1 | 2019-06-24 |
| Completed | Efficacy and Systemic Safety of Netarsudil 0.01%, 0.02%, 0.04% Relative to Placebo in Subjects With Open-angle Open Angle Glaucoma, Ocular Hypertension | Phase 2 | 2019-03-19 |
| Completed | Study Assessing AR-1105 in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO) Macular Edema | Phase 2 | 2019-03-13 |
| Completed | Study of Rhopressa® for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular Hyp Glaucoma, Open-Angle, Ocular Hypertension | Phase 4 | 2018-12-27 |
| Completed | Study of Netarsudil Ophthalmic Solution in Japanese/Japanese-American Subjects With Open-angle Glaucoma or Ocu Primary Open Angle Glaucoma or Ocular Hypertension | Phase 2 | 2017-11-15 |
| Completed | Study of Netarsudil Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma (POAG) or Ocular Hyperten Primary Open Angle Glaucoma or Ocular Hypertension | Phase 2 | 2017-10-20 |
| Completed | Safety and Efficacy Study of PG324 (Netarsudil/Latanoprost 0.02% / 0.005%) Ophthalmic Solution Compared to GAN Open Angle Glaucoma, Ocular Hypertension | Phase 3 | 2017-09-05 |
| Completed | Nocturnal/Diurnal Intraocular Pressure-Lowering Effect of Netarsudil Ophthalmic Solution Ocular Hypertension, Open Angle Glaucoma | Phase 2 | 2016-07-01 |
| Completed | Double-masked Study of PG324 Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular Hypertension Open-angle Glaucoma, Ocular Hypertension | Phase 3 | 2016-02-01 |
| Completed | Double-masked Study of PG324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension Open-angle Glaucoma, Ocular Hypertension | Phase 3 | 2015-09-18 |
| Completed | Double-masked Study of Netarsudil (AR-13324) Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertens Open-angle Glaucoma, Ocular Hypertension | Phase 3 | 2015-09-01 |
| Completed | A Controlled Study of the Aqueous Humor Dynamics of AR-13324 Ophthalmic Solution in Healthy Adult Volunteers Healthy Subjects | Phase 1 | 2015-04-01 |
| Completed | Study of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension Ocular Hypertension, Glaucoma | Phase 3 | 2014-09-01 |
| Completed | Double-masked Study of AR-13324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension Ocular Hypertension, Open-angle Glaucoma | Phase 3 | 2014-07-01 |
| Completed | Evaluation of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma and Ocular Hypertension Ocular Hypertension, Open-angle Glaucoma | Phase 3 | 2014-07-01 |
| Completed | Study Assessing Safety and Efficacy of PG324 Ophthalmic Solution in Patients With Elevated Intraocular Pressur Open Angle Glaucoma, Ocular Hypertension | Phase 2 | 2014-01-01 |
| Completed | Study Assessing Ocular and Systemic Safety of AR-13324 in Healthy Volunteers Healthy | Phase 1 | 2013-11-01 |
| Completed | A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days Open Angle Glaucoma, Ocular Hypertension | Phase 2 | 2013-02-01 |
| Completed | Study Comparing the Safety and Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular Press Ocular Hypertension, Open Angle Glaucoma | Phase 2 | 2012-11-01 |
| Completed | A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Ocular Hypertension, Open-angle Glaucoma | Phase 2 | 2012-10-01 |
| Completed | Study of AR-13324 in Patients With Elevated Intraocular Pressure Ocular Hypertension, Open Angle Glaucoma | Phase 2 | 2012-03-01 |
| Completed | AR-12286 Fixed Dose Combination to Lower Elevated Intraocular Pressure Glaucoma, Ocular Hypertension | Phase 2 | 2011-12-01 |
| Completed | 24-hour Efficacy of AR-12286 Open Angle Glaucoma, Ocular Hypertension | Phase 2 | 2011-05-01 |
| Completed | AR-12286 in Combination With Latanoprost Glaucoma, Ocular Hypertension | Phase 2 | 2011-02-01 |
| Completed | Formulation Comparison in Normal Volunteers Normal Volunteers | Phase 1 | 2010-11-01 |
| Completed | Study of AR-12286 Versus Latanoprost in Patients With Elevated Intraocular Pressure Glaucoma | Phase 2 | 2010-02-01 |
| Completed | A Study of AR-12286 in Patient With Elevated Intraocular Pressure (IOP) Elevated Intraocular Pressure | Phase 2 | 2009-05-01 |
| Completed | Ocular Hypotensive Efficacy of AR-102 Glaucoma | Phase 2 | 2007-09-01 |